1.00 / AMA PRA Category 1 CreditTM 1.00 / CE for Nurses
Jointly provided by Med Learning Group and Ultimate Medical Academy/Complete Conference Management
Supported by an educational grant from Genenetech, Inc.
This case-based enduring activity will cover the treatment and management of patients with multiple sclerosis (MS).
This activity is designed to meet the needs of neurologists, nurses, nurse practitioners, and other healthcare professionals treating patients with MS.
Upon completion of the program, participants should be able to:
Identify differences in MS between African Americans and Caucasians and implement ways to overcome these disparities.
Review the safety and efficacy of current and emerging agents used for MS, with particular attention on the African American population.
Identify barriers and unmet needs from the patient perspective that lead to low adherence and poor outcomes.
Assess ways in which to more openly communicate with patients of any ethnicity in order to encourage their engagement across all aspects of their care.
Conflict Of Interest Disclosure Policy
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Patricia Coyle, MD Professor and Vice Chair (Clinical Affairs) Director, MS Comprehensive Care Center Stony Brook University Medical Center Stony Brook, NY
Dr. Coyle has received consulting fees from AbbVie, Accordant, Acorda, Bayer, Biogen, Celgene, Genentech/Roche, Genzyme/Sanofi, Mallinckrodt, Novartis, Serono, and Teva and research support from Actelion, Novartis, Opexa, and Genentech Roche and NINDS.
Mary Hughes, MD Neurologist Premier Neurology Associate Professor of Neurology University of South Carolina - Greenville Greenville, SC
Dr. Hughes has served on the speakers bureau for Genentech, Biogen, and Teva.
June Halper, MSN, APN-C, MSCN, FAAN Certified Adult Nurse Practitioner CEO of the CMSC and IOMSN Hackensack, NJ
Ms. Halper, has no financial relationships to disclose.
Planners, Managers, and Reviewers Disclosures
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Chris Drury, MS, MA, Medical and Scientific Services for Med Learning Group, has nothing to disclose. Matthew Frese MBA, General Manager of Med Learning Group, has nothing to disclose. Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose. Lisa Dorin, Senior Program Manager for Med Learning Group, has nothing to disclose. Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
Nurse Reviewer – Barbara O’Brien, RN, MSN, has nothing to disclose.
AMA PRA Category 1 Credit(s)TM
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Med Learning Group designates this enduring activity for a maximum of 1.00 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
CE for Nurses
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.00 contact hour(s) of continuing nursing education of RNs and APNs.
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.